Abstract
Teratology is the discipline dealing with the causes and the development of congenital malformations. As used here, congenital malformations are gross structural anomalies of prenatal origin. In the widest sense, teratogens include endogenous factors (i.e., point mutations or chromosomal aberrations) as well as exogenous agents. There has been a tendency to forget these facts, as teratology has come to be associated with “environment,” whereas properly it should carry no such connotation.
Supported in part by NIH grant HD03502.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
J. G. Wilson, Teratogenic interaction of chemical agents in the rat, J. Pharmacol Exp. Therap. 144, 429–436 (1964).
H. Kalter, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 57–80, University of Chicago Press, Chicago (1965).
M. J. Edwards, Congenital defects in guinea pigs: Fetal resorptions, abortions, and malformations following induced hyperthermia during early gestation, Teratology 2, 313–328 (1969).
L. B. Russell, in “Radiation Biology” (A. Hollaender, ed.) Vol. 1, Part 2, pp. 861–918, McGraw-Hill, New York (1954).
W. L. Russell, Studies in mammalian radiation genetics, Nucleonics 23, 53–56, 62 (Jan., 1965).
S. P. Hicks and C. J. D’Amato, Effects of ionizing radiations on mammalian development, Adv. Teratol. 1, 196–250 (1966).
E. L. Green, Genetic effects of radiation on mammalian populations, Ann. Rev. Genet. 2, 87–120 (1968).
H. Kalter, “Teratology of the Central Nervous System, ” University of Chicago Press, Chicago (1968).
L. B. Russell, Chromosome aberrations in experimental animals, Prog. Med. Genet. 2, 230–294 (1962).
A. J. Bateman, Testing chemicals for mutagenicity in a mammal, Nature 210, 205–206 (1966).
G. Röhrborn, Mutagenicity tests in mice. I. The dominant lethal method and the control problem, Humangenetik 6, 345–361 (1968).
W. L. Russell, X-ray-induced mutations in mice, Cold Spring Harbor Symp. Quant. Biol. 16, 327–336 (1951).
G. D. Snell, X-ray sterility in the male house mouse, J. Exp. Zool. 65, 421–441 (1933).
G. D. Snell, The induction by X-rays of hereditary changes in mice, Genetics 20, 545–567 (1935).
H. H. Strandskov, Effects of X-rays in an inbred strain of guinea pigs, J. Exp. Zool. 63, 175–202 (1932).
W. L. Russell, in “Radiation Biology” (A. Hollaender, ed.) Vol. 1, Part 2, pp. 825–859, McGraw-Hill, New York (1954).
P. C. Koller and C. A. Auerbach, Chromosome breakage and sterility in the mouse, Nature 148, 501–502 (1941).
P. C. Koller, Segmental interchange in mice, Genetics 29, 247–263 (1944).
G. D. Snell, An analysis of translocations in the mouse, Genetics 31, 157–180 (1946).
A. B. Griffen, in “Biology of the Laboratory Mouse” (E. L. Green, ed.) 2nd ed., pp. 51–85, McGraw-Hill, New York (1966).
C. Auerbach, The chemical production of mutations, Science 158, 1141–1147 (1967).
H. Jackson, The effects of alkylating agents on fertility, Brit. Med. Bull. 20, 107–114 (1964).
A. Fave, Les embryopathies provoquées chez les mammifères, Thérapie 19, 43–164 (1964).
H. Nishimura, “Chemistry and Prevention of Congenital Anomalies, ” Charles C Thomas, Springfield, I11. (1964).
D. A. Karnofsky, Drugs as teratogens in animals and man, Ann. Rev. Pharmacol. 5, 447–472 (1965).
F. Vichi, P. L. Masi, P. Pierleoni, S. Orlando, L. Pagni, and I. Tollaro, “I Fattori Metagenetici Esogeni nelle Malformazioni Congenita (Oro-maxillofaciali): Teratogenesi Sperimentale e Riferimenti Clinici, ” Minerva Medica, Saluzzo (1966).
S. Chaube and M. L. Murphy, Teratogenic effects of the recent drugs active in cancer chemotherapy, Adv. Teratol. 3, 181–237 (1968).
M. L. Murphy, A. Del Moro, and C. Lacon, Comparative effects of five polyfunctional alkylating agents on the rat fetus, with additional notes on the chick embryo, Ann. N.Y. Acad. Sci. 68, 762–781 (1958).
D. S. Falconer, B. M. Slizynski, and C. Auerbach, Genetical effects of nitrogen mustard in the house mouse, J. Genet. 51, 81–88 (1952).
B. M. Cattanach, Chemically induced mutations in mice, Mutation Res. 3, 346–353 (1966).
G. Röhrborn and F. Vogel, A search for dominant mutations in F1 progeny of male mice treated with trenimone (triethyleneiminobenzoquinone-1, 4), Humangenetik 7, 43–50 (1969).
B. M. Cattanach, The sensitivity of the mouse testis to the mutagenic action of triethylenemelamine, Z. Vererb. 90, 1–6 (1959).
B. M. Cattanach, Induction of translocations in mice by triethylenemelamine, Nature 180, 1364–1365 (1957).
G. D. Snell, Induction by roentgen rays of hereditary changes in mice, Radiology, 36, 189–194 (1941).
W. L. Russell and L. B. Russell, The genetic and phenotypic characteristics of radiation-induced mutations in mice, Radiat. Res. Suppl. 1, 296–305 (1959).
C. Ockey, T. Hsu, and L. Richardson, Chromosome damage induced by 5-fluoro-2′-deoxyuridine (FUDR) in relation to the cell cycle of the Chinese hamster, J. Nat. Cancer Inst. 40, 465–475 (1968).
G. D. Snell, E. Bodemann, and W. Hollander, A translocation in the house mouse and its effect on development, J. Exp. Zool. 67, 93–104 (1934).
E. M. Otis, Prenatal Mortality Rates of Seventeen Radiation Induced Translocations in Mice, University of Rochester Atomic Energy Report UR-291 (1953).
J. Warkany and R. C. Nelson, Skeletal abnormalities in offspring of rats reared on deficient diets, Anat. Rec. 79, 83–100 (1941).
J. Gillman, C. Gilbert, T. Gillman, and I. Spence, A preliminary report on hydrocephalus, spina bifida, and other congenital anomalies in the rat produced by trypan blue, S. Afr. J. Med. Sci. 13, 47–90 (1948).
H. Kalter and J. Warkany, Congenital malformations in inbred strains of mice induced by riboflavin-deficient, galactoflavin-containing diets, J. Exp. Zool. 136, 531–566 (1957).
H. Kalter and J. Warkany, Experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis A, Am. J. Pathol. 38, 1–21 (1961).
H. Baxter and F. C. Fraser, The production of congenital defects in the offspring of female mice treated with cortisone, McGill Med. J. 19, 245–249 (1950).
J. J. Buresh and T. J. Urban, The teratogenic effect of the steroid nucleus in the rat, J. Dent. Res. 43, 548–554 (1964).
K. M. Massey, Teratogenic effects of diphenylhydantoin sodium, J. Oral Therap. Pharmacol. 2, 380–385 (1966).
K. T. Szabo, Teratogenicity of lithium in mice, Lancet 2, 849 (1969).
A. J. Bateman, The induction of dominant lethal mutations in rats and mice with triethylenemelamine (TEM), Genet. Res. 1, 381–392 (1960).
B. M. Cattanach, The effect of triethylene-melamine on the fertility of female mice, Internat. J. Radiat. Biol. 3, 288–292 (1959).
G. Röhrborn, Über einen Geschlechtsunterschied in der mutagenen Wirkung von Trenimon bei der Maus, Humangenetik 2, 81–82 (1966).
G. Röhrborn and H. Berrang, Dominant lethals in young female mice, Mutation Res. 4, 231–233 (1967).
W. M. Generoso and W. L. Russell, Strain and sex variations in the sensitivity of mice to dominant-lethal induction with ethyl methanesulfonate, Mut. Res. 8, 589–598 (1969).
C. P. Dagg, in “Biology of the Laboratory Mouse” (E. L. Green, ed.) 2nd ed., pp. 309–328, McGraw-Hill, New York (1966).
M. Smithberg, Teratogenesis in inbred strains of mice, Adv. Teratol. 2, 257–288 (1967).
J. Wilson, Embryological considerations in teratology, Ann. N.Y. Acad. Sci. 123, 219–227 (1965).
J. G. Wilson, Differentiation and reaction of rat embryos to radiation, J. Cell. Comp. Physiol. 43, Suppl., 11–37 (1954).
L. B. Russell and W. L. Russell, An analysis of the changing radiation response of the developing mouse embryo, J. Cell. Comp. Physiol. 43, Suppl., 103–147 (1954).
L. B. Russell and M. H. Major, Radiation-induced presumed somatic mutations in the house mouse, Genetics 42, 161–175 (1957).
S. Soukup, E. Takacs, and J. Warkany, Chromosome changes in embryos treated with various teratogens, J. Embryol. Exp. Morphol. 18, 215–228 (1967).
T. H. Ingalls, E. F. Ingenito, and F. J. Curley, Acquired chromosomal anomalies induced in mice by injection of a teratogen in pregnancy, Science 141, 810–812 (1963).
A. Endo and T. H. Ingalls, Chromosomal anomalies in embryos of diabetic mice, Arch. Env. Hlth., 16, 316–325 (1968).
Commission on Drug Safety, “Report. Conference on Prenatal Effects of Drugs, ” Chicago (1963).
H. Vagtborg, ed., “Use of Nonhuman Primates in Drug Evaluation, ” University of Texas Press, Austin (1968).
C. O. Miller, ed., “Proceedings. Conference on Nonhuman Primate Toxicology, ” U.S. Department of Health, Education, and Welfare, Washington, D.C. (1968).
B. B. Brodie and W. D. Reid, Is man a unique animal in response to drugs? Am. J. Pharm. 141, 21–27 (1969).
J. V. Neel, “Changing Perspectives on the Genetic Effects of Radiation, ” Charles C Thomas, Springfield, Ill. (1963).
J. V. Neel, Atomic bombs, inbreeding, and Japanese genes: The Russel Lecture for 1966, Univ. Mich. Med. Cent. J. 32, 107–116 (1966).
W. J. Schull, J. V. Neel, and A. Hashizume, Some further observations on the sex ratio among infants born to survivors of the atomic bombings of Hiroshima and Nagasaki, Am. J. Hum. Genet. 18, 328–338 (1966).
C. Auerbach and D. S. Falconer, A new mutant in the progeny of mice treated with nitrogen mustard, Nature 163, 678–679 (1949).
R. G. Edwards, The experimental induction of gynogenesis in the mouse. III. Treatment of sperm with trypaflavine, toludine blue, or nitrogen mustard, Proc. Roy. Soc. London, Series B 149, 117–129 (1958).
B. M. Cattanach, in “Effects of Ionizing Radiation on the Reproductive System” (W. D. Carlson and F. X. Gassner, eds.) pp. 415–431, Macmillan, New York (1964).
D. Haskin, Some effects of nitrogen mustard on the development of external body form in the fetal rat, Anat. Rec. 102, 493–511 (1948).
S. P. Hicks, Some effects of ionizing radiation and metabolic inhibition on developing mammalian nervous system, J. Pediat. 40, 489–513 (1952).
C. H. Danforth and E. Center, Nitrogen mustard as a teratogenic agent in the mouse, Proc. Soc. Exp. Biol. Med. 86, 705–707 (1954).
O. Thalhammer and E. Heller-Szöllösy, Exogene Bildungsfehler (“Missbildungen”) durch Lostinjection bei der graviden Maus, Z. Kinderheilk. 76, 351–365 (1955).
M. L. Murphy and D. A. Karnofsky, Effect of azaserine and other growthinhibiting agents on fetal development of the rat, Cancer 9, 955–962 (1956).
M. L. Murphy, C. P. Dagg, and D. A. Karnofsky, Comparison of teratogenic chemicals in the rat and chick embryos, Pediatrics 19, 701–714 (1957).
H. Nishimura and S. Takagaki, Congenital malformations in mice induced by nitrogen mustard, Acta Schol. Med. Univ. Kioto Jap. 36, 20–26 (1959).
A. Jurand, Further investigations on the cytotoxic and morphogenetic effects of some nitrogen mustard derivatives, J. Embryol. Exp. Morphol. 9, 492–506 (1961).
R. L. Brent, B. T. Bolden, and J. B. Franklin, The evaluation of teratogenic agents by means of the uterine vascular clamping technique, Am. J. Dis. Child. 104, 464–654, abst. (1962).
M. L. Murphy, Teratogenic effects in rats of growth inhibiting chemicals, including studies on thalidomide, Clin. Proc. Child. Hosp. (Washington, D.C.) 18, 307–322 (1962).
N. Brock and T. von Kreybig, Experimenteller Beitrag zur Prüfung teratogener Wirkungen von Arzneimitteln an der Laboratoriumsratte, Naunyn- Schmiedebergs Arch. Exp. Pathol. 249, 117–145 (1964).
M. Müller and N. Škreb, Does nitrogen mustard mimic the X-ray effects in any case? Experientia 20, 70–71 (1964).
M. Müller, Does nitrogen mustard affect the foetus directly or secondarily by its effects on the mother? Experientia 22, 247 (1966).
R. A. Hettig, G. G. Robertson, and D. T. Cline, Effect of nitrogen mustard injections on the embryos of pregnant rats, J. Lab. Clin. Med. 36, 833–834, abst. (1950).
I. Hayashi, T. Yama, and H. Fujii, Experimental studies on the relationship between embryonic environment and developmental anomalies, Acta Pathol. Jap. 7, 444–445, abst. (1957).
K. Okano, J. Esumi, S. Ito, S. Kashiyama, H. Fujita, T. Toba, and H. Ito, Influences of nitromin on rat embryo, Acta Pathol. Jap. 8, 561, abst. (1958).
A. Jurand, Anti-mesodermal activity of a nitrogen mustard derivative. J. Embryol. Exp. Morphol. 11, 689–696 (1963).
J. Jackson, B. W. Fox, and A. W. Craig, The effect of alkylating agents on male rat fertility, Brit. J. Pharmacol 14, 149–157 (1959).
V. A. Alexandrov, Characteristics of the pathogenic action of sarcolysin on the embryogenesis of rats, Dokl. Akad. Nauk. SSSR 171, 746–749 (1966).
H. Jackson, Antifertility substances, Pharmacol Rev. 11, 135–172 (1959).
K. Didcock, D. Jackson, and J. M. Robson, The action of some nucleotoxic substances on pregnancy, Brit. J. Pharmacol. 11, 437–441 (1956).
I. W. Monie, Chlorambucil-induced abnormalities of the urogenital system of rat fetuses, Anat. Rec. 139, 145–153 (1961).
H. Tuchmann-Duplessis and L. Mercier-Parot, Répercussions des neuroleptiques et des antitumoraux sur le développement prénatal, Bull. Acad. Suisse Sci. Med. 20, 490–526 (1964).
S. Chaube, G. Kury, and M. L. Murphy, Teratogenic effects of cyclophosphamide (NSC-26271) in the rat, Cancer Chemotherap. Rep. 51, 363–376 (1967).
D. Brittinger, Die mutagene Wirkung von Endoxan bei der Maus, Humangenetik 3, 156–165 (1966).
E. Schleiermacher, Über den Einfluss von Trenimon und Endoxan auf die Meiose der männlichen Maus. II. Cytogenetische Befunde nach Behandlung mit Trenimon und Endoxan, Humangenetik 3, 134–155 (1966).
P. Gerlinger, Action du cyclophosphamide injecté à la mère sur la réalisation de la forme du corps des embryons de lapin, Compt. Rend. Soc. Biol. 158, 2154–2157 (1964).
P. Gerlinger and J. Clavert, Action du cyclophosphamide injecté à des lapines gestantes sur les gonades embryonnaires, Compt. Rend. Acad. Sci. 258, 2899–2901 (1964).
P. Gerlinger and J. Clavert, Action du cyclophosphamide injecté à différentes périodes de la gestation sur les cellules sexuelles embryonnaires de lapin, Compt. Rend. Soc. Biol. 158, 2464–2466 (1964).
P. Gerlinger and J. Clavert, Etude de l’évolution des cellules sexuelles d’embryons issus de lapines traitées au cyclophosphamide, Compt. Rend. Soc. Biol. 159, 1386–1389 (1965).
P. Gerlinger and J. Clavert, Anomalies observées chez des lapins issues de mères traitées au cyclophosphamide, Compt. Rend. Soc. Biol. 159, 1462–1466 (1965).
I. Hackenberger and T. von Kreybig, Vergleichende teratologische Untersuchungen bei der Maus und der Ratte, Arzneimittelforschung 15, 1456–1460 (1965).
T. von Kreybig, Die teratogene Wirkung von Cyclophosphamid während der embryonalen Entwicklungsphase bei der Ratte, Naunyn-Schmiedebergs Arch. Exp. Pathol. 252, 173–195 (1965).
T. von Kreybig, Zür Wirkung von Teratogenen auf frühe Stadien der vorgeburtlichen Entwicklung der Ratte„ Naunyn-Schmiedebergs Arch. Exp. Pathol. 252, 196–204 (1965).
T. von Kreybig, Extremitätsmissbildungen im Tierexperiment, Arzneimittelforschung 15, 1213–1217 (1965).
R. Shoji and E. Ohzu, Effect of endoxan on developing mouse embryos, J. Fac. Sci. 15, 662–665 (1965).
T. von Kreybig and W. Schmidt, Zur chemischen Teratogenese bei der Ratte, Arzneimittelforschung 16, 989–1000 (1966).
T. von Kreybig and W. Schmidt, Chemisch induzierte Fetopathien bei der Ratte. Experimentelle Untersuchungen über die Wirkung von Cyclophosphamid und N-Methyl-N-nitroso-Harnstoff nach der Gabe am 15. oder 16. Tag des Gestation, Arzneimittelforschung 17, 1093–1099 (1967).
J. E. Gibson and B. A. Becker, The teratogenicity of cyclophosphamide in mice, Cancer Res. 28, 475–480 (1968).
J. E. Gibson and B. A. Becker, Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice, Teratology 1, 393–398 (1968).
C. E. Adams, M. F. Hay, and C. Lutwak-Mann, The action of various agents upon the rabbit embryo, J. Embryol. Exp. Morphol. 9, 468–491 (1961).
U. H. Ehling, R. B. Cumming, and H. V. Malling, Induction of dominant lethal mutations by alkylating agents in male mice, Mutation Res. 5, 417–428 (1968).
W. M. Generoso, Chemical induction of dominant lethals in female mice, Genetics 61, 461–470 (1969).
H Jackson and M. Bock, The effect of triethylamine on the fertility of rats, Nature 175, 1037–1038 (1955).
M. Bock and H. Jackson, The action of triethylenemelamine on the fertility of male rats, Brit. J. Pharmacol. 12, 1–7 (1957).
B. M. Cattanach and R. G. Edwards, The effects of triethylenemelamine on the fertility of male mice, Proc. Roy. Soc. Edinburgh, Series B, 67, 54–64 (1958).
E. Steinberger, W. O. Nelson, A. Boccabella, and W. J. Dixon, A radiomimetic effect of triethylenemelamine on reproduction in the male rat, Endocrinology 65, 40–50 (1959).
J. K. Sherman and E. Steinberger, Effect of triethylenemelamine on reproductive capacity of mouse spermatozoa, Proc. Soc. Exp. Biol. Med. 103, 348–350 (1960).
B. M. Cattanach, A chemically-induced variegated-type position effect in the mouse, Z. Vererb. 92, 165–182 (1961).
B. M. Cattanach, Induction of paternal sex-chromosome losses and deletions and of autosomal gene mutations by the treatment of mouse post-meiotic germ cells with triethylenemelamine, Mutation Res. 4, 73–82 (1967).
B. N. Hemsworth and H. Jackson, in “Embryopathic Activity of Drugs” (J. M. Robson, F. M. Sullivan, and R. L. Smith, eds.) pp. 116–137, Little, Brown, Boston (1965).
S. S. Epstein and H. Shafner, Chemical mutagens in the human environment, Nature 219, 385–386 (1968).
J. B. Thiersch, Effect of 2, 4, 6 triamino-“s”-triazene (TR) 2, 4, 6 “tris” (ethyleneimino)-“s”-triazene (TEM) and N, N′, N″-triethylenephosphoramide (TEPA) on rat litter in utero, Proc. Soc. Exp. Biol. Med. 94, 36–40 (1957).
H. Tuchmann-Duplessis and L. Mercier-Parot, Sur l’action tératogène de quelques substances antimitotiques chez le rat, Compt. Rend. Acad. Sci. 247, 152–154 (1958).
A. Jurand, Action of triethanomelamine (TEM) on early and late stages of mouse embryos, J. Embryol Exp. Morphol 7, 526–539 (1959).
M. Kageyama, Multiple development anomalies in offspring of albino mice mice injected with triethylenemelamine (TEM) during pregnancy [in Japanese with English summary], Acta Anat. Nippon. 36, 10–23 (1961).
M. Kageyama and H. Nishimura, Developmental anomalies in mouse embryos induced by triethylenemelamine (TEM), Acta Schol. Med. Univ. Kioto Jap. 37, 318–327 (1961).
S. Sobin, Experimental creation of cardiac defects, Proc. M. R. Pediat. Res. Conf. 14, 13–16 (1955).
N. I. Nuzhdin and G. V. Nizhnik, Fertilization and embryonic development of rabbits following in vitro treatment of spermatozoa with chemical mutagens [in Russian], Dokl. Akad. Nauk. SSSR 181, 224–227 (1968).
K. Okano, H. Fujita, I. Ito, S. Kashiyama, K. Esumi, H. Ito, and T. Toba, Effects of thio-TEPA on fetus of albino rats, Acta Pathol Jap. 9, 644–645 abst. (1959).
T. Tanimura and H. Nishimura, Teratogenic effect of thio-TEPA, a potent antineoplastic compound, upon the offspring of pregnant mice [in Japanese], Acta Anat. Nippon. 37, 66–67 (1962).
H. Nanjo, Maldevelopment of the fetuses caused by maternal administration of thio-TEPA in relation to maternal age [in Japanese with English summary], Acta Anat. Nippon. 39, 258–262 (1964).
M. Nishikawa, Teratogenic effect of combined administration of fasting and thio-TEPA upon mouse embryos [in Japanese with English summary], Acta Anat. Nippon. 39, 252–257 (1964).
K. Takano, T. Tanimura, and H. Nishimura, The susceptibility of the offspring of alloxan-diabetic mice to a teratogen, J. Embryol. Exp. Morphol. 14, 63–73 (1965).
H. Nishimura, M. Terada, and M. Yasuda, Mitigated teratogenicity of thio-TEPA in the goldthioglucose obese mice, Proc. Soc. Exp. Biol. Med. 124, 1190–1193 (1967).
T. Tanimura, Relationship of dosage and time of administration to teratogenic effects of thio-TEPA in mice, Okaj. Folia Anat. Jap. 44, 337–355 (1968).
T. B. Gaines and R. D. Kimbrough, The sterilizing, carcinogenic and teratogenic effects of metepa in rats, Bull. World Health Org. 34, 317–320 (1966).
G. Röhrborn, Die mutagene Wirkung von Trenimon bei der männlichen Maus, Humangenetik 1, 576–578 (1965).
S. Sokół, The influence of the drug Bayer E-39 [Improquone] solubile on the embryonic development of the rat, Folia Biol. 14, 317–330 (1966).
W. Zimmermann and G. H. M. Gottschewski, Die Wirkung bestimmter Substanzen auf die DNS- und Proteinsynthese in der frühen Embryonalentwicklung des Kaninchens, Bull. Schweiz. Akad. Med. Wiss. 22, 166–183 (1966).
R. L. Younger, Probable induction of congenital anomalies in a lamb by apholate, Am. J. Vet. Res. 26, 991–995 (1965).
A. M. Malashenko and I. K. Yegorov, The induction of dominant lethals in inbred mice by ethylene imine [in Russian with summary in English], Genetika 3, 59–67 (1967).
A. M. Malashenko and I. K. Yegorov, The induction of dominant lethals in male mice with ethylene and diethylsulphate [in Russian with summary in English], Genetika 4, 21–27 (1968).
W. Bollag, Cytostatica in der Schwangerschaft, Schweiz. Med. Woch. 84, 393–395 (1954).
B. N. Hemsworth and H. Jackson, Effect of busulphan on the developing gonad of the male rat, J. Reprod. Fert. 5, 187–194 (1963).
B. N. Hemsworth and H. Jackson, Effect of busulphan on the developing ovary in the rat, J. Reprod. Fert. 6, 229–233 (1963).
M. Partington and H. Jackson, The induction of dominant lethal mutations in rats by alkane sulphonic esters, Genet. Res. 4, 333–345 (1963).
A. E. Light, Additional observations on the effects of busulfan on cataract formation, duration of anesthesia, and reproduction in rats, Toxicol. Appl. Pharmacol. 10, 459–466 (1967).
U. H. Ehling and H. V. Mailing, 1, 4 di(methane-sulfonoxy) butane (Myleran) as a mutagenic agent in mice, Genetics 60, 174–175, abst. (1968).
B. H. Hemsworth and H. Jackson, in “Embryopathic Activity of Drugs” (J. M. Robson, F. M. Sullivan, and R. L. Smith, eds.) pp. 116–137, Little, Brown, Boston (1965).
V. A. Alexandrov, Pathological effect of myelosan on embryogenesis [in Russian], Dokl. Akad. Nauk. SSSR 159, 918–920 (1964).
V. A. Alexandrov, The role of allantois injury in the pathogeny of antenatal death and certain embryopathies in rats treated with myelosane (mylerane). The critical period of allantois development in rats [in Russian], Dokl. Akad. Nauk. SSSR 162, 232–235 (1965).
V. A. Alexandrov, Teratogenous effect of antileukemic drug—myelosan (mileran) on rat embryo [in Russian with English summary], Arkh. Anat. 44, 87–94 (1965).
V. A. Alexandrov, Analysis of the lethal effect of ‘myleran’ on rat embryos, Nature 209, 1215–1216 (1966).
V. A. Alexandrov, Characteristics of disturbance of embryogenesis under the action of myelosan in the early stages of the development of the rat [in Russian], Biull. Eksp. Biol. Med. 61, 81–84 (1966).
J.-G. Forsberg and H. Olivecrona, The effect of prenatally administered busulphan on rat gonads, Biol. Neonat. 10, 180–192 (1966).
Y. Kameyama, T. Sugawara, T. Ogawa, K. Hoshino, and U. Murakami, Effects of myleran on the development of the skeletal system in the rat and mouse embryos, Ann. Rep. Res. Inst. Environ. Med. Nagoya Univ. 14, 61–78 (1966).
B. N. Hemsworth, Embryopathies in the rat due to alkane sulphonates, J. Reprod. Fert. 17, 325–334 (1968).
H. Jackson, B. W. Fox, and A. W. Craig, Antifertility substances and their assessment in the male rodent, J. Reprod. Fert. 2, 447–465 (1961).
H. Jackson, M. Partington, and A. L. Walpole, Production of heritable partial sterility in the mouse by methyl methanesulphonate, Brit. J. Pharmacol. Chemotherap. 23, 521–528 (1964).
M. Partington and A. J. Bateman, Dominant lethal mutations induced in male mice by methylmethanesulphonate, Heredity 19, 191–200 (1964).
B. N. Hemsworth, Effect of alkane sulphonic esters on ovarian development and function in the rat, J. Reprod. Fert. 18, 15–20 (1969).
B. M. Cattanach, C. E. Pollard, and J. H. Isaacson, Ethyl methanesulfonateinduced chromosome breakage in the mouse, Mutation Res. 6, 297–307 (1968).
U. H. Ehling, D. G. Doherty, and H. V. Malling, Differential mutagenic action of n- and iso-propyl methanesulfonate in mice, Proc. XII Int. Cong. Genet. 1, 103, abst. (1968).
K. H. Baldermann, G. Röhrborn, and T. M. Schroeder, Mutagenitätsuntersuchungen mit Trypaflavin und Hexamethylentetramin am Säuger in vivo und in vitro, Humangenetik 4, 112–126 (1967).
H. F. Hintz, H. Heitman, Jr., A. N. Booth, and W. E. Gagne, Effects of aflatoxin on reproduction in swine, Proc. Soc. Exp. Biol. Med. 126, 146–148 (1967).
J. A. DiPaolo, J. Elis, and H. Erwin, Teratogenic response by hamsters, rats and mice to aflatoxin B1, Nature 215, 638–639 (1967).
R. H. Rigdon and E. G. Rennels, Effect of feeding benzpyrene on reproduction in the rat, Experientia 20, 224–226 (1964).
R. H. Rigdon and J. Neal, Effects of feeding benzo(a)pyrene on fertility, embryos, and young mice, J. Nat. Cancer Inst. 34, 297–306 (1965).
H. Jackson and A. R. Jones, Antifertility action and metabolism of trimethylphosphate in rodents, Nature 220, 591–592 (1968).
G. Röhrborn and F. Vogel, Mutationen durch chemische Einwirkung bei Säuger und Mensch. 2. Genetische Untersuchungen an der Maus, Deut. Med. Woch. 92, 2315–2321 (1967).
M. L. Murphy and S. Chaube, Preliminary survey of hydroxyurea (NSC-32065) as a teratogen, Cancer Chemotherap. Rep. 40, 1–7 (1964).
M. L. Murphy, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 161–184, University of Chicago Press, Chicago (1965).
V. H. Ferm, Teratogenic activity of hydroxy urea, Lancet 1, 1338–1339 (1965).
V. H. Ferm, Severe developmental malformations. Malformations induced by urethane and hydroxyurea in the hamster, Arch. Pathol. 81, 174–177 (1966).
S. Chaube and M. L. Murphy, The effects of hydroxyurea and related compounds on the rat fetus, Cancer Res. 26, 1448–1457 (1966).
T. von Kreybig, R. Preussmann, and W. Schmidt, Chemische Konstitution und teratogene Wirkung bei der Ratte. I. Carbonsäureamide, Carbonsäurehydrazide und Hydroxamsäuren, Arzneimittelforschung 18, 645–657 (1968).
V. Lauro, F. E. S. Giornelli, A. Fanelli, and C. Giornelli, Inibitori metabolici e fertilità: Indagine sugli effecti dell’idrossiurea nella ratta, Arch. Ostet. Ginec. 73, 451–462 (1968).
R. Roll and F. Bar, Untersuchingen über die teratogene Wirkung von Hydroxyharnstoff während der frühen und embryonalen Entwicklung der Maus, Arch. Toxik. 25, 150–168 (1969).
V. H. Ferm, Teratogenic effect of dimethyl sulphoxide, Lancet 1, 208–209 (1966).
V. H. Ferm, Congenital malformations induced by dimethyl sulphoxide in the golden hamster, J. Embryol. Exp. Morphol. 16, 49–54 (1966).
M. Marin-Padilla, Mesodermal alterations induced by dimethyl sulfoxide, Proc. Soc. Exp. Biol. Med. 122, 717–720 (1966).
F. M. E. Caujolle, D. H. Caujolle, S. B. Cros, and M.-M. J. Calvet, Limits of toxic and teratogenic tolerance of dimethyl sulfoxide, Ann. N. Y. Acad. Sci. 141, 110–125 (1967).
M. B. Juma and R. E. Staples, Effect of maternal administration of dimethyl sulfoxide on the development of rat fetuses, Proc. Soc. Exp. Biol. Med. 125, 566–569 (1967).
J. G. Sinclair, A specific transplacental effect of urethane in mice, Texas Rep. Biol. Med. 8, 623–632 (1950).
E. K. Hall, Developmental anomalies in the eye of the rat after various experimental procedures, Anat. Rec. 116, 383–394 (1953).
H. Nishimura and M. Kuginuki, Congenital malformations induced by ethylurethan in mouse embryos, Folia Anat. Jap. 31, 1–10 (1958).
S. L. Kauffman, Early morphologic changes in mouse embryo neural tube following transplacental exposure to urethane, Ped. Proc. 23, 128, abst. (1964).
K. Tsuchikawa and A. Akabori, Differences of the response to teratogens between inbred strains of mice. (1) Differences of the response to ethylurethane between strain CBA and C3HeB/Fe, Proc. Congen. Anom. Res. Ass. Jap. 4, 48, abst. (1964).
K. Tsuchikawa and A. Akabori, Strain differences of susceptibility to induced congenital anomalies in mice, Proc. Congen. Anom. Res. Assoc. Jap. 5, 2, abst. (1964).
S. Takekoshi, Effects of urethan on the teratogenic action of hypervitaminosis A, Gumma J. Med. Sci. 14, 210–212 (1965).
J. G. Sinclair and B. E. Abreu, Transplacental effects of drugs in mice, Texas Rep. Biol. Med. 23, 849–853 (1965).
S. Takaori, K. Tanabe, and K. Shimamoto, Developmental abnormalities of skeletal system induced by ethylurethan in the rat, Jap. J. Pharmacol. 16, 63–73 (1966).
T. Tanaka, Postnatal fate of Polydactyly induced by administration of ethylurethane to pregnant mice, Acta Anat. Nippon. 41, 299–305 (1966).
J. A. DiPaolo and J. Elis, Comparison of teratogenic and carcinogenic effects of some carbamate compounds, Cancer Res. 27, 1969–1702 (1967).
S. L. Kauffman and L. Herman, Ultrastructural changes in embryonic mouse neural tube cells after urethane exposure, Dev. Biol. 17, 55–74 (1968).
S. L. Kauffman, Cell proliferation in embryonic mouse neural tube following urethane exposure, Dev. Biol. 20, 146–157 (1969).
S. Peters and M. Strassburg, Stress als teratogener Faktor. Tierexperimentelle Untersuchingen zur Erzeugung von Gaumenspalten, Arzneimittel Forschung 19, 1106–1111 (1969).
N.-J. Höglund, Effects of ethyl urethane on reproduction in mice, Acta Pharmacol. 8, 82–84 (1952).
T. von Kreybig, Verschiedene Wirkmechanismen in teratologischen Experiment, Naunyn-Schmiedebergs Arch. Exp. Pathol. 251, 197–198 (1965).
S. D. Vesselinovitch, N. Mihailovich, and G. Pietra, The prenatal exposure of mice to urethan and the consequent development of tumors in various tissues, Cancer Res. 27, 2333–2337 (1967).
J. A. DiPaolo, Polydactylism in the offspring of mice injected with 5-bromo-deoxyuridine, Science 145, 501–503 (1964).
P. R. Ruffolo and V. H. Ferm, The teratogenicity of 5-bromodeoxyuridine in the pregnant Syrian hamster, Life Sci. 4, 633–637 (1965).
P. R. Ruffolo and V. H. Ferm, The embryocidal and teratogenic effects of 5-bromodeoxyuridine in the pregnant hamster, Lab. Invest. 14, 1547–1553 (1965).
G. Sansone and C. Zunin, Embriopatie sperimentali da deficienza di acido folico nel ratto, prodotte mediante somministrazione di aminopterina, Bull. Soc. Ital. Biol. Sper. 29, 1697–1699 (1953).
G. Sansone and C. Zunin, Embriopatie sperimentali da somministrazione di antifolico, Acta Vitamin. 8, 73–79 (1954).
H. J. K. Obbink, Bijdrage tot de kennis omtrent de oorzaken van aangeboren misvormingen van niet-erfelijke oorsprong. Een experimenteel onderzoek bij ratten over het verband tussen foliumzuurdeficientie tijdens de zwangerschap en het onstaan van aangeboren hydrocephalus [in Dutch with English summary], Mededel. Lab. Physiol. Chem. Univ. Amsterdam Ned. Inst. Volksvoed 16, 1–132 (1955–57).
S. Kotani, E. Araki, K. Yukioka, T. Inaba, S. Nakamura, and T. Miyoshi, Experimentally produced congenital anomalies through folic acid deficiency [in Japanese with English summary], J. Osaka City Med. Cent. 7, 353–359 (1958).
C. S. Kinney and L. M. Morse, Effect of a folic acid antagonist, aminopterin, on fetal development and nucleic acid metabolism in the rat, J. Nutr. 84, 288–294 (1964).
V. S. Baranov, The peculiar features of the injuring effect of aminopterin at different stages of rat embryogenesis [in Russian], Dokl. Akad. Nauk. SSSR 163, 1032–1035 (1965).
V. S. Baranov, The specificity of the teratogenic effect of aminopterin as compared to other teratogenic agents [in Russian with English summary], Biull. Eksp. Biol. Med. 61, 77–82 (1966).
L. F. James and R. F. Keeler, Teratogenic effects of aminopterin in sheep, Teratology 1, 407–412 (1968).
J. B. Thiersch and F. S. Philips, Effect of 4-aminopteroylglutamic acid (aminopterin) on early pregnancy, Proc. Soc. Exp. Biol. Med. 74, 204–208 (1950).
M. L. Murphy, Effects of antimetabolites on development of the fetal rat, Am. J. Dis. Child. 96, 533–534, abst. (1958).
M. L. Murphy, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 145–161, University of Chicago Press, Chicago (1965).
N. N. Slonitskaya, Teratogenic effect of griseofulvin-forte on rat fetus [in Russian with English summary], Antibiotiki 14, 44–47 (1969).
B. M. Cattanach, Lack of effect of nicotine on the fertility of male and female mice, Z. Vererb. 93, 351–355 (1962).
H. Nishimura and K. Nakai, Developmental anomalies in offspring of pregnant mice treated with nicotine, Science 127, 877–878 (1958).
H. Nanjo, Maldevelopment of the fetuses caused by maternal administration of nicotine during pregnancy in relation to maternal age [in Japanese with English summary], Acta. Anat. Nippon. 39, 212–216 (1964).
J. M. Mallette and B. C. Y. Man, Some effects of maternal intake of nicotine on fetal mice, Am. Zool. 6, 611, abst. (1966).
D. Vara and O. Kinnunen, Effect of nicotine on the female rabbit and developing fetus, Ann. Med. Exp. Biol. Fenniae 29, 202–213 (1951).
L. M. Geller, Failure of nicotine to affect development of offspring when administered to pregnant rats, Science 129, 212–214 (1959).
H. D. Mosier and M. K. Armstrong, Effects of maternal intake of nicotine on fetal and newborn rats, Proc. Soc. Exp. Blol. Med. 116, 956–958 (1964).
R. Becker, J. E. King, and C. R. D. Little, Delayed birth in experimental animals and its relation to the postmaturity syndrome, Anat. Rec. 154, 315, abst. (1966).
H. D. Mosier, Jr., and M. K. Armstrong, Effect of maternal nicotine intake on fetal weight and length in rats, Proc. Soc. Exp. Biol. Med. 124, 1135–1137 (1967).
M. F. Lyon, R. J. S. Phillips, and A. G. Searle, A test for mutagenicity of caffeine in mice, Z. Vererb. 93, 7–13 (1962).
B. M. Cattanach, Genetical effects of caffeine in mice, Z. Vererb. 93, 215–219 (1962).
W. Kuhlmann, H. Fromme, E. Heege, and W. Ostertag, The mutagenic action of caffeine in higher organisms, Cancer Res. 28, 2375–2389 (1968).
I. D. Adler, Does caffeine induce dominant lethal mutations in mice? Humangenetik 7, 137–148 (1969).
H. Nishimura and K. Nakai, Congenital malformations in offspring of mice treated with caffeine, Proc. Soc. Exp. Biol. Med. 104, 140–142 (1960).
C. Knoche and J. König, Zur pränatalen Toxizität von Diphenylpyralin-8-chlor-theophyllinat unter Berücksichtigung von Erfahrungen mit Thalidomid und Koffein, Arzneimittel Forschung 14, 415–424 (1964).
M. Bertrand, E. Schwam, A. Frandon, A. Vagne, and J. Alary, Sur un effet tératogène systématique et spécifique de la caféine chez les rongeurs, Compt. Rend. Soc. Biol. 159, 2199–2202 (1965).
T. Fujii, H. Sasaki, and H. Nishimura, Teratogenicity of caffeine in mice related to its mode of administration, Jap. J. Pharmacol. 19, 134–138 (1969).
A. Georges and J. Denef, Les anomalies digitales: Manifestations tératogéni-ques des dérivés xanthiques chez le rat, Arch. Internat. Pharmacodyn. Thérap. 172, 219–222 (1968).
B. K. Batra, The effect of methylcholanthrene painting of the ovaries on the progeny of mice, Acta Union Internat. Contra. Cancer 15, 128–133 (1959).
S. Fabro, R. L. Smith, and R. T. Williams, Embryotoxic activity of some pesticides and drugs related to phthalimide, Food Cosmetol. Toxicol. 3, 587–590 (1965).
G. Kennedy, O. E. Fancher, and J. C. Calandra, An investigation of the teratogenic potential of captan, folpet and difolatan, Toxicol. Appl. Pharmacol. 13, 420–430 (1968).
Y. Chambon, Action de la chlorpromazine sur l’évolution et l’avenir de la gestation chez le rat, Ann. Endocrinol. 16, 912–922 (1955).
F. Bovet-Nitti and D. Bovet, Action of some sympatholytic agents on pregnancy in the rat, Proc. Soc. Exp. Biol. Med. 100, 555–557 (1959).
O. D. Murphree, B. L. Monroe, and L. D. Seager, Survival of offspring of of rats administered phenothiazines during pregnancy, J. Neuropsychiat. 3, 295–297 (1962).
J. M. Ordy, A. Latanick, R. Johnson, and L. Massopust, Chlorpromazine effects on pregnancy and offspring in mice, Proc. Soc. Exp. Biol. Med. 113, 833–866 (1963).
C. Rolsten, Effects of chlorpromazine and psilocin on pregnancy of C57BL/10 mice and their offspring at birth, Anat. Rec. 157, 311, abst. (1967).
S. Ranström, Stress and pregnancy, Acta Pathol. Microbiol. Scand. Suppl. 111, 113–114 (1956).
L. B. Schnürer, Maternal and foetal responses to chronic stress in pregnancy, Acta Endocrinol. Suppl. 80, 1–96 (1963).
D. J. Clegg, Absence of teratogenic effect of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) in rats and mice, Food Cosmetol. Toxicol. 3, 387–403 (1965).
M. C. Chang, Artificial production of monstrosities in the rabbit, Nature 154, 150 (1944).
R. G. Edwards, Colchicine-induced heteroploidy in the mouse. I. The induction of triploidy by treatment of the gametes, J. Exp. Zool. 137, 317–348 (1958).
J. H. Van Dyke and M. G. Ritchey, Colchicine influence during embryonic development in rats, Anat. Rec. 97, 375, abst. (1947).
B. P. Wiesner, M. Wolfe, and J. Yudkin, The effects of some antimitotic compounds on pregnancy in the mouse, Studies Fert. 9, 129–136 (1958).
V. H. Ferm, Colchicine teratogenesis in hamster embryos, Proc. Soc. Exp. Biol. Med. 112, 775–778 (1963).
V. H. Ferm, Effect of transplacental mitotic inhibitors on the fetal hamster eye, Anat. Rec. 148, 129–138 (1964).
V. H. Ferm, The rapid detection of teratogenic activity, Lab. Invest. 14, 1500–1505 (1965).
R. Shoji and S. Makino, Preliminary notes on the teratogenic and embryocidal effects of colchicine on mouse embryos, Proc. Jap. Acad. 42, 822–827 (1966).
G. L. Vankin and H. J. Grass, Colcemid-induced teratogenesis in hybrid mouse embryos, Am. Zool. 6, 551, abst. (1966).
J. M. Morris, G. van Wagenen, G. D. Hurteau, D. W. Johnston, and R. A. Carlsen, Compounds interfering with ovum implantation and development. I. Alkaloids and antimetabolites, Fert. Ster. 18, 7–17 (1967).
T. H. Ingalls, F. J. Curley, and P. Zappasodi, Colchicine-induced craniofacial defects in the mouse embryo, Arch. Environ. Health 16, 326–332 (1967).
T. Kerr, On the effects of colchicine treatment of mouse embryos, Proc. Zool. Soc. London 116, 551–564 (1947).
C. H. Conaway, Embryo resorption and placental scar formation in the rat, J. Mammalol. 36, 516–532 (1955).
J. B. Thiersch, Effect of N-desacetyl thio colchicine (TC) and N-desacetylmethyl-colchicine (MC) on rat fetus and litter in utero, Proc. Soc. Exp. Biol. Med. 98, 479–485 (1958).
W. Gibel, E. Geibler, K. H. Lohs, H. Hilscher, G. P. Wildner, and S. Wittbrodt, Untersuchungen zur Frage einer möglichen mutagenen Wirkung von Fuselöl, Arch. Geschwulstforsch. 33, 49–54 (1969).
A. V. Bespamyatnova, S. D. Zaugalnikov. and Yu. Z. Sukhov, Embryotoxic and teratogenic action of ethylene-imine [in Russian with English summary]. Farmakol. Toksik. 33, 357–360 (1970).
E. Le Breton, C. Frayssment, C. Lafarge, and A. M. De Recondo. Aflatoxine—mécanisme de l’action, Food Cosm. Toxic. 2, 674–677 (1964).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Kalter, H. (1971). Correlation Between Teratogenic and Mutagenic Effects of Chemicals in Mammals. In: Hollaender, A. (eds) Chemical Mutagens. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8966-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8966-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8968-6
Online ISBN: 978-1-4615-8966-2
eBook Packages: Springer Book Archive